Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • Lentiviral vectors (LVs) are used for delivery of genes into hematopoietic stem and progenitor cells (HSPCs) in clinical trials worldwide. LVs, in contrast to retroviral vectors, are not associated with insertion site-associated malignant clonal expansions and, thus, are considered safer. Here, however, we present a case of markedly abnormal dysplastic clonal hematopoiesis affecting the erythroid, myeloid, and megakaryocytic lineages in a rhesus macaque transplanted with HSPCs that were transduced with a LV containing a strong retroviral murine┬ástem cell virus (MSCV) constitutive promoter-enhancer in the LTR. Nine insertions were mapped in the abnormal clone, resulting in overexpression and aberrant splicing of several genes of interest, including the cytokine stem cell factor and the transcription factor PLAG1. This case represents the first clear link between lentiviral insertion-induced clonal expansion and a clinically abnormal transformed phenotype following transduction of normal primate or human HSPCs, which is concerning, and suggests that strong constitutive promoters should not be included in LVs.


  • Espinoza, Diego A
  • Fan, Xing
  • Yang, Di
  • Cordes, Stefan F
  • Truitt, Lauren L
  • Calvo, Katherine R
  • Yabe, Idalia M
  • Demirci, Selami
  • Hope, Kristin
  • Hong, So Gun
  • Krouse, Allen
  • Metzger, Mark
  • Bonifacino, Aylin
  • Lu, Rong
  • Uchida, Naoya
  • Tisdale, John F
  • Wu, Xiaolin
  • DeRavin, Suk See
  • Malech, Harry L
  • Donahue, Robert E
  • Wu, Chuanfeng
  • Dunbar, Cynthia E

publication date

  • June 2019

has subject area